[HTML][HTML] IL-1β/IL-6/CRP and IL-18/ferritin: distinct inflammatory programs in infections

J Slaats, J Ten Oever, FL van de Veerdonk… - PLoS …, 2016 - journals.plos.org
The host inflammatory response against infections is characterized by the release of pro-
inflammatory cytokines and acute-phase proteins, driving both innate and adaptive arms of …

Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism (s): a critical discussion

DK Ingawale, SK Mandlik, SR Naik - Environmental toxicology and …, 2014 - Elsevier
Liver is a primary organ involved in biotransformation of food and drugs. Hepatic diseases
are a major worldwide problem. Hepatic disorders are mainly caused by toxic chemicals …

[HTML][HTML] Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy

H Li, MH Huang, JD Jiang, ZG Peng - World journal of …, 2018 - ncbi.nlm.nih.gov
Hepatitis C virus (HCV) infection commonly causes progressive liver diseases that
deteriorate from chronic inflammation to fibrosis, cirrhosis and even to hepatocellular …

[HTML][HTML] The complex interplay between chronic inflammation, the microbiome, and cancer: understanding disease progression and what we can do to prevent it

H Armstrong, M Bording-Jorgensen, S Dijk, E Wine - Cancers, 2018 - mdpi.com
Cancer is a multifaceted condition, in which a senescent cell begins dividing in an irregular
manner due to various factors such as DNA damage, growth factors and inflammation …

Silymarin impacts on immune system as an immunomodulator: One key for many locks

N Esmaeil, SB Anaraki, M Gharagozloo… - International …, 2017 - Elsevier
Silymarin is a flavonoid complex extracted from the Silybum marianum plant. It acts as a
strong antioxidant and free radical scavenger by different mechanisms. But in addition to …

Inhibition of T-cell inflammatory cytokines, hepatocyte NF-κB signaling, and HCV infection by standardized silymarin

SJ Polyak, C Morishima, MC Shuhart, CC Wang, Y Liu… - Gastroenterology, 2007 - Elsevier
Background & Aims: Chronic hepatitis C is a serious global medical problem necessitating
effective treatment. Because standard of care with pegylated interferon plus ribavirin therapy …

Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta‐analysis

Y Shi, YH Wu, W Wu, WJ Zhang, J Yang… - Liver …, 2012 - Wiley Online Library
Background: The association between occult hepatitis B virus (HBV) infection and
hepatocellular carcinoma (HCC) remains controversial. Aims: We conducted a meta …

[HTML][HTML] Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection

S Bala, Y Tilahun, O Taha, H Alao, K Kodys… - Journal of translational …, 2012 - Springer
Abstract Background Hepatitis C Virus (HCV), a single stranded RNA virus, affects millions
of people worldwide and leads to chronic infection characterized by chronic inflammation in …

Role of inflammation in virus pathogenesis during pregnancy

A Chudnovets, J Liu, H Narasimhan, Y Liu… - Journal of …, 2020 - Am Soc Microbiol
Viral infections during pregnancy lead to a spectrum of maternal and fetal outcomes, ranging
from asymptomatic disease to more critical conditions presenting with severe maternal …

Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma

R Tao, S Hu, S Wang, X Zhou, Q Zhang… - …, 2015 - academic.oup.com
The growth arrest special 5 (GAS5) is known to be involved in various cancers. However, its
expression regulation remains unclear. Polymorphisms in the promoter region of GAS5 may …